Charles Schwab
AGRX

Charles Schwab’s Agile Therapeutics AGRX Stock Holding History

Charles Schwab’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-16
Closed -$42K – 3565
2021
Q2 		$42K Sell
16
-74
-82% -$244K ﹤0.01% 3395
2021
Q1 		$376K Buy
90
+4
+5% +$21.6K ﹤0.01% 3177
2020
Q4 		$495K Hold
86
– – ﹤0.01% 2998
2020
Q3 		$524K Sell
86
-3
-3% -$17.2K ﹤0.01% 2865
2020
Q2 		$494K Buy
+89
New +$462K ﹤0.01% 2834
2017
Q2 		– Sell
-7
Closed -$44K – 3154
2017
Q1 		$44K Hold
7
– – ﹤0.01% 3043
2016
Q4 		$77K Hold
7
– – ﹤0.01% 3055
2016
Q3 		$94K Hold
7
– – ﹤0.01% 3015
2016
Q2 		$103K Hold
7
– – ﹤0.01% 3052
2016
Q1 		$84K Hold
7
– – ﹤0.01% 3001
2015
Q4 		$132K Hold
7
– – ﹤0.01% 3023
2015
Q3 		$91K Hold
7
– – ﹤0.01% 3044
2015
Q2 		$116K Buy
+7
New +$149K ﹤0.01% 3041

Other funds holding AGRX

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $528B AUM 27.57% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return